Cabozanix 20 Mg (Cabozantinib) – 90 Capsules

$ 810.00

Cabozanix 20 MG, a breakthrough anticancer medicine based on cabozantinib, is intended to treat advanced liver (hepatocellular carcinoma), kidney (renal cell carcinoma), and thyroid tumors (medullary thyroid carcinoma). It works as a tyrosine kinase inhibitor (TKI) by targeting critical receptors such as VEGFR, MET, and AXL to prevent tumor development, angiogenesis, and metastasis. This multi-targeted approach improves treatment outcomes by delaying disease progression and reducing tumor size. It is available for a Affordable price of $810.00 at Unitpharmacy!


 

Product Feature:


Manufacturer :  Beacon Pharmaceuticals Ltd.
Indication :  Tyrosine Kinase Inhibitor.
Generic :  Cabozantinib
Formulation :  Capsule
Pack Size :  90 Capsules
Strengths :  20 mg
Storage :  Below 25°C
Registrations :  Export Only